SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-20-120965
Filing Date
2020-11-03
Accepted
2020-11-03 16:23:07
Documents
1
Group Members
JOSHUA LANDESNELSON OBUSWYNNEFIELD CAPITAL MANAGEMENT, LLCWYNNEFIELD CAPITAL, INC.WYNNEFIELD CAPITAL, INC. PROFIT SHARING PLANWYNNEFIELD PARTNERS SMALL CAP VALUE, L.P.WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2034430d2_sc13da.htm SC 13D/A 151641
  Complete submission text file 0001104659-20-120965.txt   153543
Mailing Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123
Business Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123 212-760-0814
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Filed by) CIK: 0001251565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Subject) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85226 | Film No.: 201283793
SIC: 2834 Pharmaceutical Preparations